Design, Synthesis and Biological Evaluation of 3,9-diazatetraasteranes as Novel Matrilysin Inhibitors
摘要:
Matrilysin is an ideal biological target to develop novel inhibitors because it is overexpressed in malignant tumour cells. A series of 3,9‐diazatetraasteranes was designed as inhibitors of matrilysin, which was an ideal biological target because it is responsible for aggressive malignant phenotypes and poor prognoses implicated in many cancers. Docking simulation supported the initial pharmacophore hypothesis and suggested a common interaction mechanism of 3,9‐diazatetraasteranes with the catalytic site of matrilysin. The 3,9‐diazatetraasteranes were synthesized by the photocyclization of 4‐aryl‐1,4‐dihydropyridines, and their structures were determined using 1H NMR, 13C NMR and MS. The inhibitory activities of these compounds on matrilysin were investigated in vitro using an MTT assay in A549 (small cell lung cancer) cells. The results show that the 3,9‐diazatetraasteranes can inhibit the growth of A549 tumour cells. The best IC50 value is approximately 50 μm. This result indicates that 3,9‐diazatetraasteranes will be useful pharmacological tools for the investigation of matrilysin inhibitors.
Catalytic synthesis of 1,4-dihydropyridine derivatives using scandium(III) triflate
摘要:
Scandium(III) triflate smoothly catalyzed the reaction of imines with ethyl propiolate (2.5 equiv) to produce the corresponding N-substituted 1,4-dihydropyridines in good yields in toluene or BTF under reflux conditions. It also catalyzed the reaction of aniline and ethyl propiolate (3.2 equiv) to give another 1,4-dihydropyridine bearing three ester groups in moderate yield under the same conditions. (c) 2007 Elsevier Ltd. All rights reserved.
Domino Reaction of 3-(2-Formylphenoxy)propenoates and Amines: A Novel Synthesis of 1,4-Dihydropyridines from Salicaldehydes, Ethyl Propiolate, and Amines
作者:Sun-Liang Cui、Jun Wang、Xu-Feng Lin、Yan-Guang Wang
DOI:10.1021/jo7013593
日期:2007.9.1
[GRAPHICS]A novel synthesis of Hantzsch-type N-substituted 1,4-dihydropyridines from salicaldehydes, ethyl propiolate, and amines has been developed. Salicaldehydes were treated with ethyl propiolate in the presence of N-methylmorpholine to give ethyl 3-(2-formylphenoxy)propenoates. Three equivalents of ethyl 3-(2-formylphenoxy)propenoates reacted with 1 equiv of amines under trifluoroacetic acid (TFA) catalyst to furnish the corresponding N-substituted 1,4-dihydropyridines in good to excellent yields, recovering the starting material salicaldehydes. A possible mechanism for the domino process was proposed. Furthermore, the products can be easily derived via further transformations and three of them exhibited strong fluorescence (Phi(f) = 0.36-0.63).
Synthesis and electrochemical oxidation of 1-aryl-3,5-diethoxycarbonyl-2,6-unsubstituted 1,4-dihydropyridines
作者:B. S. Chekavichus、A. � Sausin'sh、V. P. Kadysh、G. Ya. Dubur、Ya. P. Stradyn'
DOI:10.1007/bf00474235
日期:1991.3
Biological evaluation of 4-aryl-1,4-dihydropyridines as VEGFR-2 kinase inhibitors
作者:W. Sun、Z. Ma、H. Yan
DOI:10.1134/s1070363216120574
日期:2016.12
Vascular endothelial growth factor-2 receptor (VEGFR-2) kinase is a promising target for the development of novel anticancer drugs. Molecular docking modeling was performed on a series of 4-aryl-1,4-dihydropyridines derivatives to evaluate the structural basis for VEGFR-2 inhibitory activity. Some 4-aryl-1,4-dihydropyridines were synthesized in the reaction of aromatic aldehydes and ethyl propiolate with anilines in acetic acid. The biological activities were evaluated against the cells A549, A431 and Hep-G2. The results indicated that 4-aryl-1,4-dihydropyridines could be the promising potential VEGFR-2 inhibitors.
Synthesis and Biological Activity of 3,9-Diazatetraasteranes as Novel EGFR Tyrosine Kinase Inhibitors
作者:Li Mao、Nana Tian、Chaochun Wei、Hongjun Wang、Hong Yan
DOI:10.1134/s1070363222030124
日期:2022.3
SAUSIN A. EH.; CHEKAVICHUS B. S.; LUSIS V. K.; DUBUR G. YA., XIMIYA GETEROTSIKL. SOEDIN., 1980, HO 4, 493-501
作者:SAUSIN A. EH.、 CHEKAVICHUS B. S.、 LUSIS V. K.、 DUBUR G. YA.